🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purposes of this study are to assess how the body handles baricitinib w...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-09
Trial ID
NCT01937026
Treatments Being Tested
The goal of this clinical trial is to determine the safety (phase II), then...
Status
Unknown
Location
St-Luc Clinics
Start Date
2023-07-01
Trial ID
NCT05914584
Treatments Being Tested
The present study is a randomized, parallel control, and double-blind trial...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-08-01
Trial ID
NCT06439615
Treatments Being Tested
The purpose of this study is to determine the effects of ciclosporin on the...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-10
Trial ID
NCT01968057
Treatments Being Tested
The reason for this long term study is to see how safe and effective the st...
Status
Terminated
Location
Achieve Clinical Research, LLC
Start Date
2019-09-09
Trial ID
NCT03843125
Treatments Being Tested
The reason for this study is to see if baricitinib is safe and effective in...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2019-07-08
Trial ID
NCT03899259
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy and safety of th...
Status
Completed
Location
University of Arizona
Start Date
2016-03-24
Trial ID
NCT02708095
Treatments Being Tested
ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2020-05-08
Trial ID
NCT04401579
Treatments Being Tested
This study will evaluate the safety, tolerability, and effects of stimulati...
Status
Recruiting
Location
Pinnacle Research Group, LLC
Start Date
2021-10-19
Trial ID
NCT05003310
Treatments Being Tested
This is a phase 2, single-center study in patients with active cutaneous DM...
Status
Withdrawn
Location
University of Washington Medical Center
Start Date
2022-06-01
Trial ID
NCT05361109
Treatments Being Tested